356.08
前日終値:
$358.29
開ける:
$354.45
24時間の取引高:
2.34M
Relative Volume:
1.28
時価総額:
$136.17B
収益:
$25.12B
当期純損益:
$3.25B
株価収益率:
42.38
EPS:
8.4018
ネットキャッシュフロー:
$4.28B
1週間 パフォーマンス:
-3.28%
1か月 パフォーマンス:
-3.12%
6か月 パフォーマンス:
-5.69%
1年 パフォーマンス:
-9.02%
Stryker Corp Stock (SYK) Company Profile
Compare SYK vs ABT, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
SYK
Stryker Corp
|
356.08 | 137.02B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
ABT
Abbott Laboratories
|
111.07 | 192.72B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
MDT
Medtronic Plc
|
101.65 | 131.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 113.11B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.80 | 45.68B | 5.88B | 1.34B | 799.60M | 2.3489 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-27 | 再開されました | TD Cowen | Hold |
| 2026-01-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | 開始されました | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | 再開されました | Citigroup | Buy |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | 開始されました | Wolfe Research | Outperform |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-22 | アップグレード | Needham | Hold → Buy |
| 2024-01-31 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | 開始されました | ROTH MKM | Buy |
| 2023-09-05 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-25 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-28 | アップグレード | Edward Jones | Hold → Buy |
| 2022-07-21 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-07-11 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-04-13 | 開始されました | Truist | Hold |
| 2022-03-16 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | 再開されました | Evercore ISI | Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | 開始されました | Loop Capital | Buy |
| 2021-09-14 | 再開されました | Raymond James | Mkt Perform |
| 2021-07-28 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | アップグレード | Evercore ISI | In-line → Outperform |
| 2021-05-25 | 開始されました | Barclays | Underweight |
| 2020-10-06 | 開始されました | Northland Capital | Market Perform |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-04-13 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2020-04-01 | ダウングレード | Goldman | Buy → Sell |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-08 | 開始されました | SunTrust | Hold |
| 2020-01-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | 繰り返されました | BTIG Research | Buy |
| 2019-11-05 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-10-30 | 繰り返されました | BofA/Merrill | Buy |
| 2019-07-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-30 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2019-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-08-16 | 開始されました | BTIG Research | Buy |
| 2018-06-27 | 開始されました | Bernstein | Mkt Perform |
| 2018-04-27 | 繰り返されました | Stifel | Buy |
すべてを表示
Stryker Corp (SYK) 最新ニュース
Stryker introduces Mako Handheld Robotics with the limited market release of Mako RPS - Finviz
Stryker launches handheld robotic system for knee replacements - Investing.com
A handheld knee surgery robot: inside Stryker's new Mako RPS system - stocktitan.net
Stryker Corporation $SYK Shares Sold by Twin Capital Management Inc. - MarketBeat
Stryker Corp(SYK.US) Director Sells US$181.72 Million in Common Stock - 富途牛牛
Insider Selling: Stryker (NYSE:SYK) Director Sells 250,000 Shares of Stock - MarketBeat
Stryker Ronda E sells Stryker Corp (SYK) stock worth $181.7 million - Investing.com
Orthopedic Implants Market Size to Reach USD 33.20 Billion by 2033, Driven by Rising Musculoskeletal Disorders and Surgical Innovation – SNS Insider - GlobeNewswire Inc.
J.W. Cole Advisors Inc. Trims Stock Position in Stryker Corporation $SYK - MarketBeat
Bear Alert: Is Stryker Corporation in a bullish channelBreakout Watch & Accurate Technical Buy Alerts - baoquankhu1.vn
Stryker Dividend Hike Highlights Shareholder Returns And Valuation Trade Offs - simplywall.st
Witnessing An Insider Decision, Spencer S Stiles Exercises Options Valued At $3.70M At Stryker - Benzinga
Stryker tops $25B in revenue and signals confidence in 2026 growth - Crain's Grand Rapids Business
Stryker declares quarterly dividend of $0.88 per share - Investing.com
Stryker declares an $0.88 per share quarterly dividend - The Globe and Mail
Jones Financial Companies Lllp Boosts Stake in Stryker Corporation $SYK - MarketBeat
Stryker group president Pierce sells $175k in shares By Investing.com - Investing.com South Africa
Stryker group president Pierce sells $175k in shares - Investing.com
10 Best Health Care Stocks to Buy for 2026 - US News Money
Stryker Corporation $SYK Shares Sold by Mediolanum International Funds Ltd - MarketBeat
Morgan Stanley Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $445 - 富途牛牛
Stryker Corporation (NYSE:SYK) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Atle Fund Management AB Has $8.42 Million Stake in Stryker Corporation $SYK - MarketBeat
Stryker (SYK) Earnings Call Highlights Growth and Resilience - TipRanks
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $387 to $465 - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Regeneron (REGN) and NewAmsterdam Pharma Company (NAMS) - The Globe and Mail
Stryker Corporation (NYSE:SYK) Q4 2025 Earnings Call Transcript - Insider Monkey
Stryker raises annual profit forecast on strong sales for medical devices - Reuters
Assessing Stryker (SYK) Valuation After Strong Results And Optimistic 2026 Growth Outlook - Yahoo Finance
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $412 to $454 - 富途牛牛
Piper Sandler Maintains Overweight Rating on Stryker Corporation (SYK) - Finviz
Stryker starts first cases with handheld ortho robot - MedTech Dive
Stryker (NYSE:SYK) Shares Gap Up Following Better-Than-Expected Earnings - MarketBeat
Stryker stock price target raised to $412 from $410 at BTIG By Investing.com - Investing.com South Africa
Evercore ISI Adjusts Stryker Price Target to $400 From $390, Maintains Outperform Rating - marketscreener.com
BTIG Research Adjusts Stryker Price Target to $412 From $410, Maintains Buy Rating - marketscreener.com
Needham raises Stryker stock price target to $454 on strong Q4 results By Investing.com - Investing.com South Africa
Barclays Adjusts Stryker Price Target to $469 From $462, Maintains Overweight Rating - marketscreener.com
Stryker (NYSE:SYK) Given New $454.00 Price Target at Needham & Company LLC - MarketBeat
Needham raises Stryker stock price target to $454 on strong Q4 results - Investing.com
Canaccord Genuity reiterates Buy rating on Stryker stock with $435 target By Investing.com - Investing.com India
Stryker (NYSE:SYK) Issues FY 2026 Earnings Guidance - MarketBeat
Canaccord Genuity reiterates Buy rating on Stryker stock with $435 target - Investing.com
Stryker rises after raising annual profit forecast - TradingView
Stryker enters 2026 with ‘strong momentum’ after FY25 revenue eclipses $25bn - Yahoo Finance
Knights of Columbus Asset Advisors LLC Has $8.95 Million Holdings in Stryker Corporation $SYK - MarketBeat
Stryker price target raised to $412 from $410 at BTIG - TipRanks
Pittenger & Anderson Inc. Acquires 11,827 Shares of Stryker Corporation $SYK - MarketBeat
Tandem Investment Advisors Inc. Acquires 7,425 Shares of Stryker Corporation $SYK - MarketBeat
The Analyst Verdict: Stryker In The Eyes Of 11 Experts - Benzinga
Stryker stock rating reiterated at Market Outperform by Citizens - Investing.com
Stryker Corp (SYK) 財務データ
収益
当期純利益
現金流量
EPS
Stryker Corp (SYK) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| STRYKER RONDA E | Director |
Feb 04 '26 |
Sale |
362.92 |
250,000 |
90,730,741 |
2,457,331 |
| Lobo Kevin | Chair and CEO |
Feb 06 '26 |
Option Exercise |
96.64 |
206,955 |
20,000,131 |
329,350 |
| Stiles Spencer S | President and COO |
Feb 03 '26 |
Option Exercise |
96.64 |
13,840 |
1,337,498 |
76,674 |
| Pierce James Andrew | Group President |
Feb 02 '26 |
Option Exercise |
96.64 |
13,840 |
1,337,498 |
79,470 |
| Pierce James Andrew | Group President |
Feb 02 '26 |
Sale |
368.87 |
475 |
175,215 |
70,563 |
大文字化:
|
ボリューム (24 時間):